文章基本信息

标题：Shanxian granule ameliorates diethylnitrosamine-induced precancerous lesions in liver by regulating inflammatory mediators
本地全文：下载
作者：Yan-fang Pan ; Xiao-tao Jia ; Xiao-ping Ying 等
期刊名称：E3S Web of Conferences
印刷版ISSN：2267-1242
电子版ISSN：2267-1242
出版年度：2020
卷号：185
页码：1-5
DOI：10.1051/e3sconf/202018503020
出版社：EDP Sciences
摘要：To explore the effects of Shanxian Giranules (SXG) on diethylnitrosamine (DEN) -inducedprecancerous lesions in rats and its possible molecular mechanism. A total of 50 male SD rats (190+10 g)were randomly divided into five groups. Control group, DEN group, SXG low dose group, SXG medium dosegroup and SXG high dose group. The control group received saline injection. The precancerous liver crthosisgroup received 50mg/kg DEN via intraperitoneal injection twice a week for 16 weeks. The indexes of liverfunction (ALT, AST and GGT) were measured by blood sampling. HE staining was used to observepathological changes of liver tissues. The levels of IL-6 and TNFa were measured by ELISA kits. Comparedwith the model group, the high (P<0.01) and middle dose (P<0.05) of SXG significantly reduced the damageof liver function and ameliorated the degree of liver disease, such as hepatic fibrosis. In addition, SXGsignificantly decreased the levels of IL-10 and TNFa in the liver of DEN-induced precancerous lesions. Inconclusion, SXG can effectively and dose-dependently alleviate the morphological changes of rat liverprecancerous lesions. And the underlying protective mechanism of SXG may be by inhibiting the release ofinflammatory mediators, such as IL-6 and TNF-a.
其他摘要：To explore the effects of Shanxian Granules (SXG) on diethylnitrosamine (DEN) -induced precancerous lesions in rats and its possible molecular mechanism. A total of 50 male SD rats (190±10 g) were randomly divided into five groups. control group, DEN group, SXG low dose group, SXG medium dose group and SXG high dose group. The control group received saline injection. The precancerous liver cirrhosis group received 50mg/kg DEN via intraperitoneal injection twice a week for 16 weeks. The indexes of liver function (ALT, AST and GGT) were measured by blood sampling. HE staining was used to observe pathological changes of liver tissues. The levels of IL-6 and TNFα were measured by ELISA kits. Compared with the model group, the high ( P <0.01) and middle dose ( P <0.05) of SXG significantly reduced the damage of liver function and ameliorated the degree of liver disease, such as hepatic fibrosis. In addition, SXG significantly decreased the levels of IL-10 and TNFα in the liver of DEN-induced precancerous lesions. In conclusion, SXG can effectively and dose-dependently alleviate the morphological changes of rat liver precancerous lesions. and the underlying protective mechanism of SXG may be by inhibiting the release of inflammatory mediators, such as IL-6 and TNF-α.